← Eichor
Study identifier: NCT07646418 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Combined Effects of LIRT-BFR Therapy in Post- Stroke Patients

Condition: Stroke  ·  Sponsor: Riphah International University

PhaseNA
Planned participants64
Who can joinAll sexes, 50 Years to 70 Years
Healthy volunteersNo

About this study

Stroke is a focal neurological deficit of sudden onset, with symptoms lasting more than 24 hours leading to consequences like impacting physical abilities, cognitive functions and emotional well-being, speech and language difficulties. Among various rehabilitation program, Blood flow restriction (BFR) therapy with low intensity resistance training has shown its promising results. Blood flow restriction training, also called Kaatsu, originated in Japan. So this study aims to determine the combined effects of Low Intensity Resistance Training with Blood Flow Restriction Therapy on Upper Limb Strength, Forward Reach and Sensorimotor function in Post-Stroke Patients.

This description comes directly from the study's public registry record.

Talk to the study team

Imran Amjad, PhD  ·  03324390125  ·  imran.amjad@riphah.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Amin Welfare & Teaching HospitalSialkot, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07646418